Sign in
Taking people in United StatesNo phase

Emergency Department Implementation of the i-STAT Alinity Traumatic Brain Injury Whole Blood Test

Key facts

Who runs it
Shawn Eagle
Where
Pittsburgh, United StatesSee the site
Trial code
Status
Recruiting
People taking part
340 people, planned
Started
13 Jan 2026
Expected to end
Apr 2030
Type of study
Observational, 2 groups
Treatments tested
  • i-STAT Alinity TBI test
Record updated
6 July 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 18 criteriaShow less

Who can take part

  • Aged 18 or older
  • Presenting to an enrolling ED with ED Arrival GCS of 13-15 following reported head blunt impact within 24 hours of injury
  • Meets Department of Defense (DoD) definition of mTBI:; A traumatically induced physiological disruption of brain function as a result of an external force that is indicated by new onset or worsening of at least one of the following clinical signs immediately following the event:
  • Any alteration of mental status (e.g., feeling dazed, disoriented, or confused)
  • Any period of loss of or a decreased level of consciousness, observed or self-report (loss of consciousness 30 minutes or less, an alteration of consciousness up to 24 hours)
  • Any loss of memory for events immediately before or after the injury (post-traumatic amnesia up to 1-day post-injury)

Who cannot take part

  • History of neurosurgical intervention for previous TBI
  • Pre-existing neurologic condition
  • History of penetrating TBI
  • Any history of brain surgery
  • Any history of brain tumor
  • Patients on psychiatric hold
  • Treating emergency department provider does not think a head CT scan is needed
  • Inability to obtain results for iSTAT Alinity TBI test within 24 hours of injury
  • Treating emergency department attending physician is not willing to participate
  • Contraindication or inability to complete blood draw
  • Significant polytrauma that, in the opinion of the principal investigators, could impact peripheral GFAP levels or require a full body scan
  • Penetrating TBI for current injury

Where in United States

  • University of PittsburghPittsburgh, United StatesContact: Shawn Eagle, PhDTaking people

About the trial

What the trial wants to find out

The objective of this study is to identify determinants for implementing the i-STAT Alinity whole blood traumatic brain injury (TBI) test for its Food and Drug Administration (FDA)-indicated use and to evaluate other potential outcomes with clinical implications. The main questions it aims to answer are:

Read full original descriptionShow less

1. Determine the number of patients with non-elevated (i.e., below clinical cutoff) whole blood iSTAT Alinity tests who also receive CT scans. 2. What are the obstacles for using the i-STAT Alinity for its FDA-indicated use

The 2 groups in the trial

  • ED Providers

    Treating providers in the emergency department

  • ED patients

    Patients in the emergency department with GCS 13-15 with suspected TBI

    Treatment: i-STAT Alinity TBI test

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effectiveness of the Traumatic Brain Injury Whole Blood Test on Improving Assessment and Triage for Patients With GCS 13-15 Presenting to Emergency Departments
Publications
Record updated
6 July 2026